Every legal way to pay for your GLP-1, with the receipts
Three questions. Every payment pathway for Zepbound, Wegovy, Ozempic, Mounjaro, Wegovy tablets and Foundayo, each with the source it came from and the date we last checked it.
Pricing data as of .
Right now, we publish no verified price
We track 45 figures across 6 medications. Not one of them currently survives our standard, which is a direct read of a manufacturer or government page rather than a search result or an aggregator. Every figure in circulation failed that check, so we show you the pathways, the evidence we hold, and a link to the official page — instead of a number we cannot stand behind.
Choose your medication and your insurance situation to see every pathway ranked by what you would actually pay this month.
Why this site and not a telehealth cost guide
Search for GLP-1 pricing and most of what ranks is published by companies that sell GLP-1 products or provider access. A page that recommends the cheapest option while selling one of the options is not a comparison, it is a funnel.
This site sells nothing. There are no telehealth links, no pharmaceutical affiliate links and no compounding-pharmacy links anywhere in it, and there is no revenue arrangement with any manufacturer or government program. What we publish instead is our work: every figure carries the source it came from, the type of that source, and the date we last checked it.
We also tell you when we do not know. Prices in this market have moved repeatedly, and a confident number that is two months old is worse than an honest gap. Where we cannot confirm a figure against a primary source, we say so and link you to the official page instead of guessing. Read the methodology.
Every medication we track
Each page carries the full pathway table for that medication, with the source and verification date on every figure.
- Zepbound cost — tirzepatide, made by Eli Lilly and Company
- Mounjaro cost — tirzepatide, made by Eli Lilly and Company
- Wegovy cost — semaglutide, made by Novo Nordisk
- Ozempic cost — semaglutide, made by Novo Nordisk
- Wegovy tablets cost — oral semaglutide, made by Novo Nordisk
- Foundayo cost — orforglipron, made by Eli Lilly and Company
Every pathway we track
- LillyDirect Self Pay — Eli Lilly's direct-to-patient cash-pay pharmacy. Requires a valid prescription. Bypasses insurance entirely, so the amount paid does not count toward any deductible or out-of-pocket maximum.
- NovoCare Pharmacy — Novo Nordisk's direct-to-patient cash-pay pharmacy. Requires a valid prescription. Bypasses insurance entirely.
- TrumpRx — Federal direct-purchase platform launched under Most-Favored-Nation pricing agreements with manufacturers. Prices on this platform have moved repeatedly since launch.
- Manufacturer savings card — A manufacturer copay card used alongside commercial insurance. Universally excludes beneficiaries of federal healthcare programs.
- Medicare GLP-1 Bridge — A Medicare access pathway reported to provide a fixed monthly beneficiary cost for a covered GLP-1, subject to clinical eligibility criteria.
- Medicare Part D — Standard Part D coverage where the plan covers the indication. Cost varies by plan, formulary tier and phase of the benefit.
- Patient assistance program — Manufacturer-funded assistance for patients below an income threshold. Income-gated and application-based.